Director/PDMR Shareholding

RNS Number : 8419X

Creo Medical Group PLC

24 December 2019

 

Creo Medical Group plc

("Creo" or the "Company")

Director / PDMR Shareholding

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that following Admission of the New Ordinary Shares today, Charles Spicer, Non-Executive Chairman and David Woods, Non-Executive Director, have purchased 13,800 and 25,000 Ordinary Shares respectively in the Fundraising, at the Issue Price of 180 pence per Ordinary Share. Following these purchases, Charles Spicer and David Woods hold 93,810 and 25,000 Ordinary Shares respectively.

Capitalised terms used, but not defined in this announcement shall have the same meaning as set out in the Circular.

The information below, set out in accordance with the requirements of the MAR, provides further detail. 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	1.    Charles Spicer 2.    David Woods
2	Reason for the notification
a)	Position/status	1.    Non-Executive Chairman 2.    Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Creo Medical Group plc
b)	LEI	213800H188ZDCWWXFA21
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of £0.001 each
	Identification code	GB00BZ1BLL44
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			1. 180p 2. 180p	1.  13,800 2.  25,000
d)	Aggregated information
	- Aggregated volume	N/A - single transaction
	- Price
e)	Date of the transaction	24 December 2019
f)	Place of the transaction	London Stock Exchange

 

END

 

 

DSHLLFFLFRLVFIA